TY  - JOUR

T1  - Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

JO  - Pharmacoeconomics

PY  - 2018/09/01

AU  - Uttley L

AU  - Bermejo I

AU  - Ren S

AU  - Martyn-St James M

AU  - Wong R

AU  - Scott DL

AU  - Young A

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-018-0639-0

VL  - 36

IS  - 9

SP  - 1063

EP  - 1072

Y2  - 2024/12/22

ER  -